{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:55:57Z","timestamp":1791845757677,"version":"4.3.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04071-1","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:04:16Z","timestamp":1739959456000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["GPT meets PubMed: a novel approach to literature review using a large language model to crowdsource migraine medication reviews"],"prefix":"10.1186","volume":"25","author":[{"given":"Elyse","family":"Mackenzie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"key":"4071_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.800605","volume":"12","author":"P Amiri","year":"2022","unstructured":"Amiri P, Kazeminasab S, Nejadghaderi SA, et al. Migraine: A Review on Its History, Global Epidemiology, Risk Factors, and Comorbidities. Front Neurol. 2022;12: 800605. https:\/\/doi.org\/10.3389\/fneur.2021.800605.","journal-title":"Front Neurol"},{"issue":"1","key":"4071_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s10194-019-0974-3","volume":"20","author":"TP Do","year":"2019","unstructured":"Do TP, Guo S, Ashina M. Therapeutic novelties in migraine: new drugs, new hope? J Headache Pain. 2019;20(1):37. https:\/\/doi.org\/10.1186\/s10194-019-0974-3.","journal-title":"J Headache Pain"},{"key":"4071_CR3","unstructured":"Try Bard, an AI experiment by Google.\u00a0https:\/\/bard.google.com.\u00a0Accessed 28\u00a0July 2023."},{"key":"4071_CR4","unstructured":"Introducing ChatGPT. https:\/\/openai.com\/blog\/chatgpt.\u00a0Accessed 28 July 2023."},{"issue":"4","key":"4071_CR5","doi-asserted-by":"publisher","first-page":"033310242311573","DOI":"10.1177\/03331024231157379","volume":"43","author":"KP Peng","year":"2023","unstructured":"Peng KP, May A. Crossing the Rubicon? The future impact of artificial intelligence on headache medicine. Cephalalgia. 2023;43(4):033310242311573. https:\/\/doi.org\/10.1177\/03331024231157379.","journal-title":"Cephalalgia"},{"issue":"5","key":"4071_CR6","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/head.14495","volume":"63","author":"F Cohen","year":"2023","unstructured":"Cohen F. The role of artificial intelligence in headache medicine: Potential and peril. Headache. 2023;63(5):694\u20136. https:\/\/doi.org\/10.1111\/head.14495.","journal-title":"Headache"},{"issue":"23","key":"4071_CR7","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1212\/WNL.0000000000207967","volume":"101","author":"MF Romano","year":"2023","unstructured":"Romano MF, Shih LC, Paschalidis IC, Au R, Kolachalama VB. Large Language Models in Neurology Research and Future Practice. Neurology. 2023;101(23):1058\u201367. https:\/\/doi.org\/10.1212\/WNL.0000000000207967.","journal-title":"Neurology"},{"issue":"1","key":"4071_CR8","doi-asserted-by":"publisher","DOI":"10.2196\/16023","volume":"8","author":"A Zunic","year":"2020","unstructured":"Zunic A, Corcoran P, Spasic I. Sentiment Analysis in Health and Well-Being: Systematic Review. JMIR Med Inform. 2020;8(1):e16023. https:\/\/doi.org\/10.2196\/16023.","journal-title":"JMIR Med Inform"},{"key":"4071_CR9","doi-asserted-by":"publisher","unstructured":"Myszewski JJ, Klossowski E, Meyer P, Bevil K, Klesius L, Schroeder KM. Validating GAN-BioBERT: A Methodology for Assessing Reporting Trends in Clinical Trials. Front Digit Health. 2022;4. https:\/\/doi.org\/10.3389\/fdgth.2022.878369.\u00a0Accessed 29 July 2023.","DOI":"10.3389\/fdgth.2022.878369"},{"key":"4071_CR10","unstructured":"Approved Drug Products with Therapeutic Equivalence Evaluations | Orange Book. FDA. Published online January 12, 2024.\u00a0https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/approved-drug-products-therapeutic-equivalence-evaluations-orange-book.\u00a0Accessed 7 Feb 2024."},{"key":"4071_CR11","unstructured":"Purple Book: Lists of Licensed Biological Products with Reference Product Exclusivity and Biosimilarity or Interchangeability Evaluations. FDA. Published online August 3, 2020. https:\/\/www.fda.gov\/drugs\/therapeutic-biologics-applications-bla\/purple-book-lists-licensed-biological-products-reference-product-exclusivity-and-biosimilarity-or. Accessed 7 Feb 2024."},{"key":"4071_CR12","unstructured":"MohamedBechirMejri\/enwords. GitHub. https:\/\/github.com\/MohamedBechirMejri\/enwords\/blob\/main\/src\/words.json. Accessed 7 Feb 2024."},{"key":"4071_CR13","first-page":"261","volume":"2023","author":"Y Guo","year":"2023","unstructured":"Guo Y, Rajwal S, Lakamana S, et al. Generalizable Natural Language Processing Framework for Migraine Reporting from Social Media. AMIA Jt Summits Transl Sci Proc. 2023;2023:261\u201370.","journal-title":"AMIA Jt Summits Transl Sci Proc"},{"issue":"7","key":"4071_CR14","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/head.14153","volume":"61","author":"J Ailani","year":"2021","unstructured":"Ailani J, Burch RC, Robbins MS, the Board of Directors of the American Headache Society. The American Headache Society Consensus Statement Update on integrating new migraine treatments into clinical practice. Headache. 2021;61(7):1021\u201339. https:\/\/doi.org\/10.1111\/head.14153.","journal-title":"Headache."},{"issue":"2","key":"4071_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12195-023-00761-3","volume":"16","author":"MR King","year":"2023","unstructured":"King MR. Can Bard, Google\u2019s Experimental Chatbot Based on the LaMDA Large Language Model, Help to Analyze the Gender and Racial Diversity of Authors in Your Cited Scientific References? Cel Mol Bioeng. 2023;16(2):175\u20139. https:\/\/doi.org\/10.1007\/s12195-023-00761-3.","journal-title":"Cel Mol Bioeng"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04071-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04071-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04071-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:04:20Z","timestamp":1739959460000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04071-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4071"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04071-1","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"assertion":[{"value":"26 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PZ: He has received honorarium from Alder Biopharmaceuticals, Board Vitals, and Fieve Clinical Research. He collaborates with Headache Science Incorporated without receiving financial support. He had ownership interest in Cymbeline LLC. He is a consultant for Acument LLC.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}